Answers are grounded in this paper and cite their sources.
Background: Esophagogastric junction (EGJ) malignancies are increasing in incidence. Surgery remains the cornerstone of curative-intent treatment. While the minimally invasive approach is ideal, it has a steep learning curve. Furthermore, the optimal approach to curative resection remains controversial. Therefore, the aim of this study was to highlight a surgical approach based on patient and tumor characteristics to achieve complete surgical (R0) resection with appropriate lymphadenectomy for EGJ malignancies during the implementation of minimally invasive en bloc esophagectomy. Methods: Patients undergoing curative-intent surgery for EGJ tumors at McGill University Health Centre during 2010–2018 were included. Data were extracted from medical records for this retrospective cohort study. A priori selection of surgical approach was biased by patient and tumor factors with a goal of achieving optimal oncological outcomes with acceptable morbidity. Surgical approach, tumor characteristics, surgical and oncologic outcomes and quality of life (QoL) were assessed. ANOVA, Kruskal-Wallis, Fisher-Exact, χ2, and log-rank tests determined statistical significance (P<0.05). Results: Curative-intent surgery was performed in 203 patients, among which 197 (97%) were R0 resections. Left thoracoabdominal (LTA), open and hybrid Ivor Lewis (IL), transabdominal (TA), and minimally invasive esophagectomy (MIE) were performed in 60 (30%), 93 (46%), 28 (14%), and 22 (11%), respectively. Patients who underwent IL had fewer comorbidities than those in LTA and MIE groups. TA comprised of the oldest patients with the highest Charlson comorbidity index (CCI). Siewert I and II tumors were approached primarily by IL. Siewert III and larger tumors tended to be managed by LTA and TA approaches. Small, early-stage tumors were approached by MIE. Lymph node retrieval was adequate [32 (24 to 46)]. Estimated blood loss [350 mL (250–500 mL)], length of stay [7 days (6–11 days)], QoL [3-year FACT-E score: 139 points (127–160 points)], and overall survival (OS) [2.5 years (1.4–4.8 years)] were comparable. Conclusions: A personalized approach is associated with appropriate R0 resection, lymphadenectomy, and long-term outcomes. A multitude of surgical options are available and the optimal surgical approach should be selected based on the patient’s disease. The framework described in this study is ideal for those who are slowly implementing MIE.
No takes yet. Share an insight, caveat, or question.
Kammili et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: